Susan Zavala Coloma
DIGEMID-General Directorate of Medicines, Supplies and Drugs
Appearances
DateAugust 11, 2021Session Speakers
Global Biotech Experts, LLCAstraZenecaGenentech, a Member of the Roche GroupHealth CanadaInmunova S.A.Eli Lilly and CompanyF. Hoffmann-La Roche Ltd.Session Chairs
Produtos Roche Químicos e Farmacêuticos S.A.Merck Serona S.A.ANMAT-National Administration of Medicines, Food and Medical TechnologyDIGEMID-General Directorate of Medicines, Supplies and DrugsPanel Members
COFEPRIS, Federal Commission for the Protection from Sanitary RisksDIGEMID-General Directorate of Medicines, Supplies and DrugsAstraZeneca
DateAugust 11, 2021Session Speakers
Global Biotech Experts, LLCAstraZenecaGenentech, a Member of the Roche GroupHealth CanadaInmunova S.A.Eli Lilly and CompanyF. Hoffmann-La Roche Ltd.Session Chairs
Produtos Roche Químicos e Farmacêuticos S.A.Merck Serona S.A.ANMAT-National Administration of Medicines, Food and Medical TechnologyDIGEMID-General Directorate of Medicines, Supplies and DrugsPanel Members
COFEPRIS, Federal Commission for the Protection from Sanitary RisksDIGEMID-General Directorate of Medicines, Supplies and DrugsAstraZeneca
DateSeptember 19, 2023TUESDAY, 19 SEPTEMBER 2023 - SESSION II: Pathway to Optimizing Submission and Review of CMC Post-Approval Changes: Employing Scientific Risk-Based Principles, Reliance Pathways, Adoption of WHO Post-Approval Guidelines, and Collaborative AssessmentsSpeakers
Seagen Inc.DIGEMID-General Directorate of Medicines, Supplies and DrugsGilead Sciences, Inc.SanofiSanofiDIGEMID-General Directorate of Medicines, Supplies and DrugsThis product is only available to members of the following groups:
- Members
DateSeptember 19, 2023TUESDAY, 19 SEPTEMBER 2023 - SESSION II: Pathway to Optimizing Submission and Review of CMC Post-Approval Changes: Employing Scientific Risk-Based Principles, Reliance Pathways, Adoption of WHO Post-Approval Guidelines, and Collaborative AssessmentsSpeakers
Seagen Inc.DIGEMID-General Directorate of Medicines, Supplies and DrugsGilead Sciences, Inc.SanofiSanofiDIGEMID-General Directorate of Medicines, Supplies and DrugsThis product is only available to members of the following groups:
- Members
DateAugust 6, 2024SESSION CHAIRS: Cammilia Horta Gomes, _Produtos Roche Quimicos e Farmaceuticos S.A…Session Chairs
DIGEMID-General Directorate of Medicines, Supplies and Drugs
